Navigation Links
IIIa in Medical News

Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting

...GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (Stage iiia or Stage IIIB) or metastatic (Stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. GEMZAR may not b...

National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting

...y: Plan of care for pain*+ AND -- Medical oncology and radiation oncology: Pain intensity quantified*+ -- Medical oncology: Chemotherapy for stage iiia through IIIC colon cancer patients* -- Oncology: Cancer stage documented* -- Medical oncology: Hormonal therapy for stage IC through IIIC, ER/PR p...

Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells

...onditions Gaucher disease, -mannosidosis, and type iiia mucopolysaccharidosis in patient-derived cell line...al storage diseases, namely -mannosidosis and type iiia mucopolysaccharidosis. People with -mannosidosis h...ections, and other complications. People with type iiia mucopolysaccharidosis have a deficiency in one of ...

Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer

...better choice than surgery for patients with stage iiia non-small-cell lung cancer, //according to a rando...CLC, about 30 percent have locally advanced stages iiia or IIIB. Previous studies have shown that treating stage iiia patients with chemotherapy before surgery increase...
IIIa in Medical Technology

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (Stage iiia or Stage IIIB) or metastatic (Stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. GEMZAR is indicate...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

...er immunotherapy. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3-positive patients with completely resected stage IB, II or iiia NSCLC in the large MAGRIT trial. The gene profiling data presented at ASCO will be further validated during the ongoing NSCLC MAGRIT Phase III trial. ...

Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting

...ETS 2 (Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets) study, showing that INTEGRILIN(R), a potent glycoprotein (GP) IIb- iiia inhibitor, significantly inhibited platelet aggregation when added to bivalirudin, compared to bivalirudin alone, in patients undergoing elective coro...

Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline

...s the MAGRIT trial (MAGE- A3 as Adjuvant Non-Small Cell Lung Cancer Immunotherapy) will target enrollment of about 2,270 patients with stage IB, II or iiia resectable NSCLC. The primary endpoint of the trial is disease-free survival. The $3 million development milestone was triggered by the initiation of ...

Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

...Cell Lung Cancer (NSCLC) Combination use: In combination with cisplatin as a first-line treatment of patients with locally advanced (inoperable Stage iiia or IIIB) or metastatic (Stage IV) NSCLC. Single-agent use: The palliative treatment of patients with locally advanced or metastatic NSCLC. Pancreati...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...contraindicated. GEMZAR is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (stage iiia or IIIB), or metastatic (stage IV) non-small cell lung cancer. GEMZAR is indicated as first-line treatment for patients with locally advanced (nonre...

Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer

...ut 2,270 MAGE-A3 positive patients with completely resected stage IB, II or iiia NSCLC. GSK's ASCIs aim to stimulate the patient's own immune response to ...l Cell Lung Cancer Immunotherapy) will enroll patients with stage IB, II or iiia resectable NSCLC. The ASCI administration will be initiated in two groups o...
IIIa in Medical Products

Streck-Lysing Agent IIIA Lytic Reagent

Description: A lytic reagent manufactured for the simultaneous quantitative determination of hemoglobin and white blood cells. Streck-Lysing Agent IIIA is manufactured specifically for use on the Abbott CELL-DYN® 1700. The shelf life is two years from date of manufacture....
Company:Streck

Streck-Diluent IIIA Balanced Electrolyte Solution

Description: Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year from date of manufacture....
Company:Streck

Streck-Detergent IIIA Balanced Electrolyte Solution

Description: Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The shelf life is two years from date of manufacture....
Company:Streck
IIIa in Biological News

Napoleon's mysterious death unmasked, UT Southwestern researcher says

...hat the cancer was large, lymph nodes were present around the stomach and there were no tumors in other organs. Only 20 percent of patients with Stage iiia gastric cancer survive five years if treated with modern surgery and chemotherapy. But what might have caused Napoleon's cancer? Risk factor...
IIIa in Biological Technology

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

...GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (Stage iiia or Stage IIIB) or metastatic (Stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. GEMZAR is indicate...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

...GEMZAR is indicated in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients with locally advanced (stage iiia or stage IIIB) or metastatic (stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. Myelosuppression is u...
Other Tags
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... which is typically used for treating colorectal cancer. It ... gastric cancer and pancreatic cancer. TS-1 is composed of ... approved in 1999 in Japan for the treatment of ...
(Date:12/25/2014)... Dylan Queen, a famous online company supplying women’s special ... prom dresses, most of which are priced under $200. ... the promotion is valid until Jan. 22, 2015; the ... market. , The prom dresses in this new collection ... strapless, empire strapless chiffon, one shoulder, floor-length, V-neck beading, ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- The risk ... the holidays, so you need to be extra cautious, ... Day, we see a significant increase in patients coming ... at the Suffolk County Volunteer Firefighters Burn Center of ... celebrations should be full of joy, but if not ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2
(Date:12/10/2014)... CIE San Diego has launched an innovative ... tissue that enhances care coordination among social service and ... information; earned a second $1 million grant from the ... aging in community and; will be recognized as a ... 4-6p. CIE San Diego today announced ...
(Date:12/5/2014)... PROVO, Utah , Dec. 4, 2014  Tute ... has raised $2.3 million in Series A1 funding led ... angel investors also participated in the investment round. ... as the healthcare community adopts next-generation sequencing and seeks ... disease," said Reid Robison , MD MBA, and ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
Other Contents